HALO vs MRNA

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 20, 2026

HALO

41.5
AI Score
VS
HALO Wins

MRNA

28.5
AI Score

Investment Advisor Scores

HALO

42score
Recommendation
HOLD

MRNA

29score
Recommendation
SELL

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric HALO MRNA Winner
Revenue 857.71M 534.00M HALO
Net Income 379.96M -2.13B HALO
Net Margin 44.3% -397.9% HALO
Operating Income 472.17M -2.20B HALO
ROE 264.7% -31.4% HALO
ROA 14.7% -19.4% HALO
Total Assets 2.58B 10.96B MRNA
Cash 163.14M 1.72B MRNA
Debt/Equity 13.50 0.09 MRNA
Current Ratio 2.71 2.29 HALO
Free Cash Flow 413.06M -1.25B HALO

Relative Price Performance (Last 90 Days)

HALO 1M: +8.4% · 3M: +54.4% MRNA 1M: +34.6% · 3M: +331.1%

Current Technical Phase

HALO

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (12.2% over 20 days), RSI 74

RSI (14): 73.7 · Price: $124.83

MRNA

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (58.0% over 20 days), RSI 69

RSI (14): 69.1 · Price: $245.81

Fundamentals Snapshot

Metric HALO MRNA
Market Cap — —
Forward P/E 11.7 -51.1
Trailing P/E 35.8 —
Revenue (TTM) — —
Revenue Growth 0.5% 0.0%
Gross Margin 0.8% -0.7%
Operating Margin 0.6% -5.6%
EPS 3.47 -7.98
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, HALO is currently the stronger investment candidate, winning 8 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.